nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—CXCL8—pancreatic cancer	0.18	0.505	CbGaD
Indomethacin—PPARG—pancreatic cancer	0.124	0.349	CbGaD
Indomethacin—PTGS2—pancreatic cancer	0.0524	0.147	CbGaD
Indomethacin—CES1—Tamoxifen—pancreatic cancer	0.0413	0.0954	CbGbCtD
Indomethacin—AKR1C3—Doxorubicin—pancreatic cancer	0.0319	0.0736	CbGbCtD
Indomethacin—CES1—Irinotecan—pancreatic cancer	0.0317	0.0733	CbGbCtD
Indomethacin—ABCC6—Doxorubicin—pancreatic cancer	0.024	0.0554	CbGbCtD
Indomethacin—ABCC3—Fluorouracil—pancreatic cancer	0.0202	0.0467	CbGbCtD
Indomethacin—UGT1A9—Irinotecan—pancreatic cancer	0.0192	0.0445	CbGbCtD
Indomethacin—UGT2B7—Epirubicin—pancreatic cancer	0.0187	0.0433	CbGbCtD
Indomethacin—UGT1A1—Erlotinib—pancreatic cancer	0.0174	0.0403	CbGbCtD
Indomethacin—SLC22A7—Fluorouracil—pancreatic cancer	0.0158	0.0365	CbGbCtD
Indomethacin—UGT1A1—Irinotecan—pancreatic cancer	0.0157	0.0364	CbGbCtD
Indomethacin—ABCC4—Fluorouracil—pancreatic cancer	0.0154	0.0357	CbGbCtD
Indomethacin—ABCC1—Epirubicin—pancreatic cancer	0.0133	0.0307	CbGbCtD
Indomethacin—ABCC1—Irinotecan—pancreatic cancer	0.0129	0.0299	CbGbCtD
Indomethacin—ABCC2—Tamoxifen—pancreatic cancer	0.0125	0.0288	CbGbCtD
Indomethacin—SLC22A7—Docetaxel—pancreatic cancer	0.0121	0.0279	CbGbCtD
Indomethacin—ABCC4—Sunitinib—pancreatic cancer	0.0117	0.0271	CbGbCtD
Indomethacin—ABCC3—Doxorubicin—pancreatic cancer	0.0115	0.0266	CbGbCtD
Indomethacin—SLCO1B1—Irinotecan—pancreatic cancer	0.0109	0.0252	CbGbCtD
Indomethacin—ABCC2—Irinotecan—pancreatic cancer	0.00957	0.0221	CbGbCtD
Indomethacin—ABCC1—Docetaxel—pancreatic cancer	0.00948	0.0219	CbGbCtD
Indomethacin—ABCC1—Doxorubicin—pancreatic cancer	0.00707	0.0163	CbGbCtD
Indomethacin—ABCC2—Docetaxel—pancreatic cancer	0.00702	0.0162	CbGbCtD
Indomethacin—ABCC2—Sunitinib—pancreatic cancer	0.00698	0.0161	CbGbCtD
Indomethacin—SLC10A1—bile duct—pancreatic cancer	0.00668	0.16	CbGeAlD
Indomethacin—ALB—Erlotinib—pancreatic cancer	0.00661	0.0153	CbGbCtD
Indomethacin—ALB—Irinotecan—pancreatic cancer	0.00597	0.0138	CbGbCtD
Indomethacin—ALB—Fluorouracil—pancreatic cancer	0.00573	0.0132	CbGbCtD
Indomethacin—ABCC2—Doxorubicin—pancreatic cancer	0.00523	0.0121	CbGbCtD
Indomethacin—SLC10A1—bile—pancreatic cancer	0.00513	0.123	CbGeAlD
Indomethacin—CYP2C19—Tamoxifen—pancreatic cancer	0.00504	0.0116	CbGbCtD
Indomethacin—ABCC3—bile duct—pancreatic cancer	0.0042	0.1	CbGeAlD
Indomethacin—CYP2C9—Tamoxifen—pancreatic cancer	0.00419	0.00968	CbGbCtD
Indomethacin—ABCB1—Tamoxifen—pancreatic cancer	0.00406	0.00939	CbGbCtD
Indomethacin—ABCB1—Gemcitabine—pancreatic cancer	0.0035	0.00809	CbGbCtD
Indomethacin—ABCB1—Erlotinib—pancreatic cancer	0.00346	0.00799	CbGbCtD
Indomethacin—ABCC2—bile duct—pancreatic cancer	0.00336	0.0802	CbGeAlD
Indomethacin—ABCB1—Irinotecan—pancreatic cancer	0.00312	0.00721	CbGbCtD
Indomethacin—CYP2C9—Fluorouracil—pancreatic cancer	0.00309	0.00713	CbGbCtD
Indomethacin—ABCC2—bile—pancreatic cancer	0.00258	0.0616	CbGeAlD
Indomethacin—ABCB1—Docetaxel—pancreatic cancer	0.00229	0.00529	CbGbCtD
Indomethacin—ABCB1—Sunitinib—pancreatic cancer	0.00228	0.00526	CbGbCtD
Indomethacin—ABCB1—Doxorubicin—pancreatic cancer	0.00171	0.00394	CbGbCtD
Indomethacin—PPARG—Topotecan—Irinotecan—pancreatic cancer	0.0015	1	CbGdCrCtD
Indomethacin—GLO1—islet of Langerhans—pancreatic cancer	0.00112	0.0267	CbGeAlD
Indomethacin—CES1—gall bladder—pancreatic cancer	0.0011	0.0263	CbGeAlD
Indomethacin—CXCL8—islet of Langerhans—pancreatic cancer	0.00103	0.0246	CbGeAlD
Indomethacin—ABCC3—gall bladder—pancreatic cancer	0.000896	0.0214	CbGeAlD
Indomethacin—Tolmetin—CXCL8—pancreatic cancer	0.000836	0.398	CrCbGaD
Indomethacin—AKR1C3—islet of Langerhans—pancreatic cancer	0.000807	0.0193	CbGeAlD
Indomethacin—GLO1—pancreas—pancreatic cancer	0.000786	0.0188	CbGeAlD
Indomethacin—ALB—gall bladder—pancreatic cancer	0.000764	0.0183	CbGeAlD
Indomethacin—PLA2G2A—pancreas—pancreatic cancer	0.000731	0.0175	CbGeAlD
Indomethacin—CXCL8—pancreas—pancreatic cancer	0.000724	0.0173	CbGeAlD
Indomethacin—PPARA—pancreas—pancreatic cancer	0.000683	0.0163	CbGeAlD
Indomethacin—GLO1—digestive system—pancreatic cancer	0.000671	0.016	CbGeAlD
Indomethacin—UGT1A9—digestive system—pancreatic cancer	0.000652	0.0156	CbGeAlD
Indomethacin—PLA2G2A—digestive system—pancreatic cancer	0.000624	0.0149	CbGeAlD
Indomethacin—PPARA—digestive system—pancreatic cancer	0.000583	0.0139	CbGeAlD
Indomethacin—AKR1C3—pancreas—pancreatic cancer	0.000567	0.0135	CbGeAlD
Indomethacin—SLC10A1—digestive system—pancreatic cancer	0.000561	0.0134	CbGeAlD
Indomethacin—PPARG—islet of Langerhans—pancreatic cancer	0.000534	0.0128	CbGeAlD
Indomethacin—UGT2B7—digestive system—pancreatic cancer	0.000525	0.0125	CbGeAlD
Indomethacin—SLC22A11—digestive system—pancreatic cancer	0.000512	0.0122	CbGeAlD
Indomethacin—SLC22A7—digestive system—pancreatic cancer	0.0005	0.0119	CbGeAlD
Indomethacin—Bezafibrate—PPARG—pancreatic cancer	0.000475	0.226	CrCbGaD
Indomethacin—UGT1A1—digestive system—pancreatic cancer	0.000447	0.0107	CbGeAlD
Indomethacin—CES1—digestive system—pancreatic cancer	0.000433	0.0103	CbGeAlD
Indomethacin—PTGS2—gall bladder—pancreatic cancer	0.000416	0.00994	CbGeAlD
Indomethacin—PPARG—pancreas—pancreatic cancer	0.000375	0.00897	CbGeAlD
Indomethacin—SLCO1B1—digestive system—pancreatic cancer	0.000372	0.00888	CbGeAlD
Indomethacin—Bromfenac—PTGS2—pancreatic cancer	0.000363	0.173	CrCbGaD
Indomethacin—ABCC3—digestive system—pancreatic cancer	0.000353	0.00842	CbGeAlD
Indomethacin—ABCC4—pancreas—pancreatic cancer	0.000341	0.00814	CbGeAlD
Indomethacin—PPARG—digestive system—pancreatic cancer	0.000321	0.00766	CbGeAlD
Indomethacin—SLCO1A2—digestive system—pancreatic cancer	0.000303	0.00723	CbGeAlD
Indomethacin—ABCC4—digestive system—pancreatic cancer	0.000291	0.00695	CbGeAlD
Indomethacin—ABCC2—digestive system—pancreatic cancer	0.000282	0.00673	CbGeAlD
Indomethacin—PTGS2—islet of Langerhans—pancreatic cancer	0.000273	0.00652	CbGeAlD
Indomethacin—Tolmetin—PTGS2—pancreatic cancer	0.000244	0.116	CrCbGaD
Indomethacin—CYP2C19—digestive system—pancreatic cancer	0.000242	0.00578	CbGeAlD
Indomethacin—PTGS2—pancreas—pancreatic cancer	0.000192	0.00458	CbGeAlD
Indomethacin—CYP2C9—digestive system—pancreatic cancer	0.000188	0.00448	CbGeAlD
Indomethacin—Naproxen—PTGS2—pancreatic cancer	0.000184	0.0873	CrCbGaD
Indomethacin—PTGS1—digestive system—pancreatic cancer	0.000171	0.00409	CbGeAlD
Indomethacin—ABCB1—islet of Langerhans—pancreatic cancer	0.000169	0.00403	CbGeAlD
Indomethacin—PTGS2—digestive system—pancreatic cancer	0.000164	0.00391	CbGeAlD
Indomethacin—ABCB1—pancreas—pancreatic cancer	0.000119	0.00283	CbGeAlD
Indomethacin—ABCB1—digestive system—pancreatic cancer	0.000101	0.00242	CbGeAlD
Indomethacin—Somnolence—Fluorouracil—pancreatic cancer	7.3e-05	0.000736	CcSEcCtD
Indomethacin—Erythema—Docetaxel—pancreatic cancer	7.26e-05	0.000732	CcSEcCtD
Indomethacin—Decreased appetite—Gemcitabine—pancreatic cancer	7.26e-05	0.000732	CcSEcCtD
Indomethacin—Dyspepsia—Fluorouracil—pancreatic cancer	7.22e-05	0.000728	CcSEcCtD
Indomethacin—Nausea—Tamoxifen—pancreatic cancer	7.21e-05	0.000727	CcSEcCtD
Indomethacin—Fatigue—Gemcitabine—pancreatic cancer	7.2e-05	0.000726	CcSEcCtD
Indomethacin—Gastritis—Epirubicin—pancreatic cancer	7.19e-05	0.000725	CcSEcCtD
Indomethacin—Muscular weakness—Epirubicin—pancreatic cancer	7.17e-05	0.000723	CcSEcCtD
Indomethacin—Pain—Gemcitabine—pancreatic cancer	7.14e-05	0.00072	CcSEcCtD
Indomethacin—Constipation—Gemcitabine—pancreatic cancer	7.14e-05	0.00072	CcSEcCtD
Indomethacin—Nausea—Erlotinib—pancreatic cancer	7.14e-05	0.00072	CcSEcCtD
Indomethacin—Decreased appetite—Fluorouracil—pancreatic cancer	7.13e-05	0.000719	CcSEcCtD
Indomethacin—Diarrhoea—Sunitinib—pancreatic cancer	7.12e-05	0.000718	CcSEcCtD
Indomethacin—Abdominal distension—Epirubicin—pancreatic cancer	7.07e-05	0.000713	CcSEcCtD
Indomethacin—Feeling abnormal—Irinotecan—pancreatic cancer	7.06e-05	0.000712	CcSEcCtD
Indomethacin—Asthma—Epirubicin—pancreatic cancer	7.03e-05	0.000708	CcSEcCtD
Indomethacin—Pain—Fluorouracil—pancreatic cancer	7.02e-05	0.000708	CcSEcCtD
Indomethacin—Gastrointestinal pain—Irinotecan—pancreatic cancer	7.01e-05	0.000707	CcSEcCtD
Indomethacin—Dizziness—Sunitinib—pancreatic cancer	6.88e-05	0.000694	CcSEcCtD
Indomethacin—Feeling abnormal—Gemcitabine—pancreatic cancer	6.88e-05	0.000694	CcSEcCtD
Indomethacin—Abdominal pain upper—Doxorubicin—pancreatic cancer	6.87e-05	0.000693	CcSEcCtD
Indomethacin—Abdominal pain—Irinotecan—pancreatic cancer	6.77e-05	0.000683	CcSEcCtD
Indomethacin—Body temperature increased—Irinotecan—pancreatic cancer	6.77e-05	0.000683	CcSEcCtD
Indomethacin—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	6.77e-05	0.000683	CcSEcCtD
Indomethacin—Feeling abnormal—Fluorouracil—pancreatic cancer	6.76e-05	0.000682	CcSEcCtD
Indomethacin—Anaemia—Docetaxel—pancreatic cancer	6.71e-05	0.000676	CcSEcCtD
Indomethacin—Pancytopenia—Epirubicin—pancreatic cancer	6.67e-05	0.000673	CcSEcCtD
Indomethacin—Gastritis—Doxorubicin—pancreatic cancer	6.66e-05	0.000671	CcSEcCtD
Indomethacin—Muscular weakness—Doxorubicin—pancreatic cancer	6.63e-05	0.000669	CcSEcCtD
Indomethacin—Vomiting—Sunitinib—pancreatic cancer	6.61e-05	0.000667	CcSEcCtD
Indomethacin—Body temperature increased—Gemcitabine—pancreatic cancer	6.6e-05	0.000665	CcSEcCtD
Indomethacin—Rash—Sunitinib—pancreatic cancer	6.56e-05	0.000661	CcSEcCtD
Indomethacin—Dermatitis—Sunitinib—pancreatic cancer	6.55e-05	0.000661	CcSEcCtD
Indomethacin—Abdominal distension—Doxorubicin—pancreatic cancer	6.54e-05	0.00066	CcSEcCtD
Indomethacin—Urticaria—Fluorouracil—pancreatic cancer	6.52e-05	0.000657	CcSEcCtD
Indomethacin—Headache—Sunitinib—pancreatic cancer	6.52e-05	0.000657	CcSEcCtD
Indomethacin—Syncope—Docetaxel—pancreatic cancer	6.51e-05	0.000656	CcSEcCtD
Indomethacin—Asthma—Doxorubicin—pancreatic cancer	6.5e-05	0.000656	CcSEcCtD
Indomethacin—Leukopenia—Docetaxel—pancreatic cancer	6.5e-05	0.000655	CcSEcCtD
Indomethacin—Pollakiuria—Epirubicin—pancreatic cancer	6.49e-05	0.000654	CcSEcCtD
Indomethacin—Body temperature increased—Fluorouracil—pancreatic cancer	6.49e-05	0.000654	CcSEcCtD
Indomethacin—Palpitations—Docetaxel—pancreatic cancer	6.41e-05	0.000647	CcSEcCtD
Indomethacin—Weight increased—Epirubicin—pancreatic cancer	6.39e-05	0.000645	CcSEcCtD
Indomethacin—Loss of consciousness—Docetaxel—pancreatic cancer	6.38e-05	0.000643	CcSEcCtD
Indomethacin—Hyperglycaemia—Epirubicin—pancreatic cancer	6.34e-05	0.000639	CcSEcCtD
Indomethacin—Hypersensitivity—Irinotecan—pancreatic cancer	6.31e-05	0.000637	CcSEcCtD
Indomethacin—Convulsion—Docetaxel—pancreatic cancer	6.29e-05	0.000634	CcSEcCtD
Indomethacin—Hypertension—Docetaxel—pancreatic cancer	6.27e-05	0.000632	CcSEcCtD
Indomethacin—Drowsiness—Epirubicin—pancreatic cancer	6.26e-05	0.000632	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	6.21e-05	0.000626	CcSEcCtD
Indomethacin—Chest pain—Docetaxel—pancreatic cancer	6.18e-05	0.000623	CcSEcCtD
Indomethacin—Nausea—Sunitinib—pancreatic cancer	6.18e-05	0.000623	CcSEcCtD
Indomethacin—Pancytopenia—Doxorubicin—pancreatic cancer	6.17e-05	0.000623	CcSEcCtD
Indomethacin—Renal failure—Epirubicin—pancreatic cancer	6.16e-05	0.000621	CcSEcCtD
Indomethacin—Asthenia—Irinotecan—pancreatic cancer	6.15e-05	0.00062	CcSEcCtD
Indomethacin—Neuropathy peripheral—Epirubicin—pancreatic cancer	6.14e-05	0.000619	CcSEcCtD
Indomethacin—Stomatitis—Epirubicin—pancreatic cancer	6.11e-05	0.000616	CcSEcCtD
Indomethacin—Jaundice—Epirubicin—pancreatic cancer	6.11e-05	0.000616	CcSEcCtD
Indomethacin—Hypersensitivity—Fluorouracil—pancreatic cancer	6.05e-05	0.00061	CcSEcCtD
Indomethacin—Sweating—Epirubicin—pancreatic cancer	6.01e-05	0.000606	CcSEcCtD
Indomethacin—Pollakiuria—Doxorubicin—pancreatic cancer	6.01e-05	0.000606	CcSEcCtD
Indomethacin—Asthenia—Gemcitabine—pancreatic cancer	5.99e-05	0.000604	CcSEcCtD
Indomethacin—Haematuria—Epirubicin—pancreatic cancer	5.97e-05	0.000602	CcSEcCtD
Indomethacin—Confusional state—Docetaxel—pancreatic cancer	5.97e-05	0.000602	CcSEcCtD
Indomethacin—Anaphylactic shock—Docetaxel—pancreatic cancer	5.92e-05	0.000597	CcSEcCtD
Indomethacin—Oedema—Docetaxel—pancreatic cancer	5.92e-05	0.000597	CcSEcCtD
Indomethacin—Weight increased—Doxorubicin—pancreatic cancer	5.92e-05	0.000597	CcSEcCtD
Indomethacin—Epistaxis—Epirubicin—pancreatic cancer	5.91e-05	0.000596	CcSEcCtD
Indomethacin—Pruritus—Gemcitabine—pancreatic cancer	5.91e-05	0.000595	CcSEcCtD
Indomethacin—Hyperglycaemia—Doxorubicin—pancreatic cancer	5.86e-05	0.000591	CcSEcCtD
Indomethacin—Diarrhoea—Irinotecan—pancreatic cancer	5.86e-05	0.000591	CcSEcCtD
Indomethacin—Agranulocytosis—Epirubicin—pancreatic cancer	5.85e-05	0.00059	CcSEcCtD
Indomethacin—Shock—Docetaxel—pancreatic cancer	5.83e-05	0.000588	CcSEcCtD
Indomethacin—Pruritus—Fluorouracil—pancreatic cancer	5.81e-05	0.000586	CcSEcCtD
Indomethacin—Thrombocytopenia—Docetaxel—pancreatic cancer	5.8e-05	0.000585	CcSEcCtD
Indomethacin—Drowsiness—Doxorubicin—pancreatic cancer	5.8e-05	0.000584	CcSEcCtD
Indomethacin—Tachycardia—Docetaxel—pancreatic cancer	5.78e-05	0.000583	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	5.75e-05	0.000579	CcSEcCtD
Indomethacin—Bradycardia—Epirubicin—pancreatic cancer	5.73e-05	0.000577	CcSEcCtD
Indomethacin—Diarrhoea—Gemcitabine—pancreatic cancer	5.71e-05	0.000576	CcSEcCtD
Indomethacin—Renal failure—Doxorubicin—pancreatic cancer	5.7e-05	0.000575	CcSEcCtD
Indomethacin—Neuropathy peripheral—Doxorubicin—pancreatic cancer	5.68e-05	0.000573	CcSEcCtD
Indomethacin—Dizziness—Irinotecan—pancreatic cancer	5.67e-05	0.000571	CcSEcCtD
Indomethacin—Haemoglobin—Epirubicin—pancreatic cancer	5.65e-05	0.00057	CcSEcCtD
Indomethacin—Stomatitis—Doxorubicin—pancreatic cancer	5.65e-05	0.00057	CcSEcCtD
Indomethacin—Jaundice—Doxorubicin—pancreatic cancer	5.65e-05	0.00057	CcSEcCtD
Indomethacin—Anorexia—Docetaxel—pancreatic cancer	5.65e-05	0.000569	CcSEcCtD
Indomethacin—Hepatitis—Epirubicin—pancreatic cancer	5.62e-05	0.000567	CcSEcCtD
Indomethacin—Haemorrhage—Epirubicin—pancreatic cancer	5.62e-05	0.000567	CcSEcCtD
Indomethacin—Diarrhoea—Fluorouracil—pancreatic cancer	5.62e-05	0.000566	CcSEcCtD
Indomethacin—Sweating—Doxorubicin—pancreatic cancer	5.56e-05	0.00056	CcSEcCtD
Indomethacin—Hypotension—Docetaxel—pancreatic cancer	5.54e-05	0.000558	CcSEcCtD
Indomethacin—Haematuria—Doxorubicin—pancreatic cancer	5.53e-05	0.000557	CcSEcCtD
Indomethacin—Epistaxis—Doxorubicin—pancreatic cancer	5.47e-05	0.000551	CcSEcCtD
Indomethacin—Vomiting—Irinotecan—pancreatic cancer	5.45e-05	0.000549	CcSEcCtD
Indomethacin—Dizziness—Fluorouracil—pancreatic cancer	5.43e-05	0.000547	CcSEcCtD
Indomethacin—Agranulocytosis—Doxorubicin—pancreatic cancer	5.41e-05	0.000545	CcSEcCtD
Indomethacin—Rash—Irinotecan—pancreatic cancer	5.4e-05	0.000545	CcSEcCtD
Indomethacin—Dermatitis—Irinotecan—pancreatic cancer	5.4e-05	0.000544	CcSEcCtD
Indomethacin—Headache—Irinotecan—pancreatic cancer	5.37e-05	0.000541	CcSEcCtD
Indomethacin—Insomnia—Docetaxel—pancreatic cancer	5.36e-05	0.00054	CcSEcCtD
Indomethacin—Paraesthesia—Docetaxel—pancreatic cancer	5.32e-05	0.000536	CcSEcCtD
Indomethacin—Erythema multiforme—Epirubicin—pancreatic cancer	5.32e-05	0.000536	CcSEcCtD
Indomethacin—Vomiting—Gemcitabine—pancreatic cancer	5.31e-05	0.000535	CcSEcCtD
Indomethacin—Bradycardia—Doxorubicin—pancreatic cancer	5.3e-05	0.000534	CcSEcCtD
Indomethacin—Dyspnoea—Docetaxel—pancreatic cancer	5.28e-05	0.000533	CcSEcCtD
Indomethacin—Somnolence—Docetaxel—pancreatic cancer	5.27e-05	0.000531	CcSEcCtD
Indomethacin—Rash—Gemcitabine—pancreatic cancer	5.26e-05	0.000531	CcSEcCtD
Indomethacin—Dermatitis—Gemcitabine—pancreatic cancer	5.26e-05	0.00053	CcSEcCtD
Indomethacin—Tinnitus—Epirubicin—pancreatic cancer	5.24e-05	0.000529	CcSEcCtD
Indomethacin—Haemoglobin—Doxorubicin—pancreatic cancer	5.23e-05	0.000527	CcSEcCtD
Indomethacin—Headache—Gemcitabine—pancreatic cancer	5.23e-05	0.000527	CcSEcCtD
Indomethacin—Flushing—Epirubicin—pancreatic cancer	5.22e-05	0.000526	CcSEcCtD
Indomethacin—Vomiting—Fluorouracil—pancreatic cancer	5.22e-05	0.000526	CcSEcCtD
Indomethacin—Dyspepsia—Docetaxel—pancreatic cancer	5.21e-05	0.000526	CcSEcCtD
Indomethacin—Hepatitis—Doxorubicin—pancreatic cancer	5.2e-05	0.000525	CcSEcCtD
Indomethacin—Haemorrhage—Doxorubicin—pancreatic cancer	5.2e-05	0.000525	CcSEcCtD
Indomethacin—Rash—Fluorouracil—pancreatic cancer	5.17e-05	0.000522	CcSEcCtD
Indomethacin—Dermatitis—Fluorouracil—pancreatic cancer	5.17e-05	0.000521	CcSEcCtD
Indomethacin—Decreased appetite—Docetaxel—pancreatic cancer	5.15e-05	0.000519	CcSEcCtD
Indomethacin—Headache—Fluorouracil—pancreatic cancer	5.14e-05	0.000518	CcSEcCtD
Indomethacin—Fatigue—Docetaxel—pancreatic cancer	5.11e-05	0.000515	CcSEcCtD
Indomethacin—Nausea—Irinotecan—pancreatic cancer	5.09e-05	0.000513	CcSEcCtD
Indomethacin—Pain—Docetaxel—pancreatic cancer	5.07e-05	0.000511	CcSEcCtD
Indomethacin—Constipation—Docetaxel—pancreatic cancer	5.07e-05	0.000511	CcSEcCtD
Indomethacin—Arrhythmia—Epirubicin—pancreatic cancer	5.02e-05	0.000507	CcSEcCtD
Indomethacin—Alopecia—Epirubicin—pancreatic cancer	4.97e-05	0.000501	CcSEcCtD
Indomethacin—Nausea—Gemcitabine—pancreatic cancer	4.96e-05	0.0005	CcSEcCtD
Indomethacin—Erythema multiforme—Doxorubicin—pancreatic cancer	4.92e-05	0.000496	CcSEcCtD
Indomethacin—Erythema—Epirubicin—pancreatic cancer	4.9e-05	0.000494	CcSEcCtD
Indomethacin—Feeling abnormal—Docetaxel—pancreatic cancer	4.88e-05	0.000492	CcSEcCtD
Indomethacin—Nausea—Fluorouracil—pancreatic cancer	4.88e-05	0.000492	CcSEcCtD
Indomethacin—Tinnitus—Doxorubicin—pancreatic cancer	4.85e-05	0.000489	CcSEcCtD
Indomethacin—Gastrointestinal pain—Docetaxel—pancreatic cancer	4.84e-05	0.000488	CcSEcCtD
Indomethacin—Flushing—Doxorubicin—pancreatic cancer	4.83e-05	0.000487	CcSEcCtD
Indomethacin—Flatulence—Epirubicin—pancreatic cancer	4.82e-05	0.000486	CcSEcCtD
Indomethacin—Tension—Epirubicin—pancreatic cancer	4.8e-05	0.000484	CcSEcCtD
Indomethacin—Nervousness—Epirubicin—pancreatic cancer	4.76e-05	0.000479	CcSEcCtD
Indomethacin—Abdominal pain—Docetaxel—pancreatic cancer	4.68e-05	0.000472	CcSEcCtD
Indomethacin—Body temperature increased—Docetaxel—pancreatic cancer	4.68e-05	0.000472	CcSEcCtD
Indomethacin—Arrhythmia—Doxorubicin—pancreatic cancer	4.65e-05	0.000469	CcSEcCtD
Indomethacin—Vision blurred—Epirubicin—pancreatic cancer	4.61e-05	0.000465	CcSEcCtD
Indomethacin—Alopecia—Doxorubicin—pancreatic cancer	4.6e-05	0.000464	CcSEcCtD
Indomethacin—Ill-defined disorder—Epirubicin—pancreatic cancer	4.54e-05	0.000458	CcSEcCtD
Indomethacin—Erythema—Doxorubicin—pancreatic cancer	4.53e-05	0.000457	CcSEcCtD
Indomethacin—Anaemia—Epirubicin—pancreatic cancer	4.52e-05	0.000456	CcSEcCtD
Indomethacin—Flatulence—Doxorubicin—pancreatic cancer	4.46e-05	0.00045	CcSEcCtD
Indomethacin—Tension—Doxorubicin—pancreatic cancer	4.45e-05	0.000448	CcSEcCtD
Indomethacin—Malaise—Epirubicin—pancreatic cancer	4.41e-05	0.000445	CcSEcCtD
Indomethacin—Nervousness—Doxorubicin—pancreatic cancer	4.4e-05	0.000444	CcSEcCtD
Indomethacin—Vertigo—Epirubicin—pancreatic cancer	4.4e-05	0.000444	CcSEcCtD
Indomethacin—Syncope—Epirubicin—pancreatic cancer	4.39e-05	0.000443	CcSEcCtD
Indomethacin—Leukopenia—Epirubicin—pancreatic cancer	4.38e-05	0.000442	CcSEcCtD
Indomethacin—Hypersensitivity—Docetaxel—pancreatic cancer	4.36e-05	0.00044	CcSEcCtD
Indomethacin—Palpitations—Epirubicin—pancreatic cancer	4.33e-05	0.000436	CcSEcCtD
Indomethacin—Loss of consciousness—Epirubicin—pancreatic cancer	4.3e-05	0.000434	CcSEcCtD
Indomethacin—Vision blurred—Doxorubicin—pancreatic cancer	4.27e-05	0.00043	CcSEcCtD
Indomethacin—Asthenia—Docetaxel—pancreatic cancer	4.25e-05	0.000429	CcSEcCtD
Indomethacin—Convulsion—Epirubicin—pancreatic cancer	4.24e-05	0.000428	CcSEcCtD
Indomethacin—Hypertension—Epirubicin—pancreatic cancer	4.23e-05	0.000426	CcSEcCtD
Indomethacin—Ill-defined disorder—Doxorubicin—pancreatic cancer	4.2e-05	0.000424	CcSEcCtD
Indomethacin—Pruritus—Docetaxel—pancreatic cancer	4.19e-05	0.000423	CcSEcCtD
Indomethacin—Anaemia—Doxorubicin—pancreatic cancer	4.19e-05	0.000422	CcSEcCtD
Indomethacin—Chest pain—Epirubicin—pancreatic cancer	4.17e-05	0.00042	CcSEcCtD
Indomethacin—Anxiety—Epirubicin—pancreatic cancer	4.15e-05	0.000419	CcSEcCtD
Indomethacin—Discomfort—Epirubicin—pancreatic cancer	4.12e-05	0.000415	CcSEcCtD
Indomethacin—Malaise—Doxorubicin—pancreatic cancer	4.09e-05	0.000412	CcSEcCtD
Indomethacin—Vertigo—Doxorubicin—pancreatic cancer	4.07e-05	0.00041	CcSEcCtD
Indomethacin—Syncope—Doxorubicin—pancreatic cancer	4.06e-05	0.00041	CcSEcCtD
Indomethacin—Leukopenia—Doxorubicin—pancreatic cancer	4.05e-05	0.000409	CcSEcCtD
Indomethacin—Diarrhoea—Docetaxel—pancreatic cancer	4.05e-05	0.000409	CcSEcCtD
Indomethacin—Confusional state—Epirubicin—pancreatic cancer	4.03e-05	0.000406	CcSEcCtD
Indomethacin—Palpitations—Doxorubicin—pancreatic cancer	4e-05	0.000404	CcSEcCtD
Indomethacin—Anaphylactic shock—Epirubicin—pancreatic cancer	4e-05	0.000403	CcSEcCtD
Indomethacin—Oedema—Epirubicin—pancreatic cancer	4e-05	0.000403	CcSEcCtD
Indomethacin—Loss of consciousness—Doxorubicin—pancreatic cancer	3.98e-05	0.000401	CcSEcCtD
Indomethacin—Shock—Epirubicin—pancreatic cancer	3.93e-05	0.000396	CcSEcCtD
Indomethacin—Convulsion—Doxorubicin—pancreatic cancer	3.92e-05	0.000396	CcSEcCtD
Indomethacin—Dizziness—Docetaxel—pancreatic cancer	3.92e-05	0.000395	CcSEcCtD
Indomethacin—Thrombocytopenia—Epirubicin—pancreatic cancer	3.91e-05	0.000394	CcSEcCtD
Indomethacin—Hypertension—Doxorubicin—pancreatic cancer	3.91e-05	0.000394	CcSEcCtD
Indomethacin—Tachycardia—Epirubicin—pancreatic cancer	3.9e-05	0.000393	CcSEcCtD
Indomethacin—Hyperhidrosis—Epirubicin—pancreatic cancer	3.86e-05	0.000389	CcSEcCtD
Indomethacin—Chest pain—Doxorubicin—pancreatic cancer	3.86e-05	0.000389	CcSEcCtD
Indomethacin—Anxiety—Doxorubicin—pancreatic cancer	3.84e-05	0.000388	CcSEcCtD
Indomethacin—Discomfort—Doxorubicin—pancreatic cancer	3.81e-05	0.000384	CcSEcCtD
Indomethacin—Anorexia—Epirubicin—pancreatic cancer	3.81e-05	0.000384	CcSEcCtD
Indomethacin—Vomiting—Docetaxel—pancreatic cancer	3.77e-05	0.00038	CcSEcCtD
Indomethacin—Rash—Docetaxel—pancreatic cancer	3.74e-05	0.000377	CcSEcCtD
Indomethacin—Hypotension—Epirubicin—pancreatic cancer	3.73e-05	0.000376	CcSEcCtD
Indomethacin—Dermatitis—Docetaxel—pancreatic cancer	3.73e-05	0.000376	CcSEcCtD
Indomethacin—Confusional state—Doxorubicin—pancreatic cancer	3.73e-05	0.000376	CcSEcCtD
Indomethacin—Headache—Docetaxel—pancreatic cancer	3.71e-05	0.000374	CcSEcCtD
Indomethacin—Anaphylactic shock—Doxorubicin—pancreatic cancer	3.7e-05	0.000373	CcSEcCtD
Indomethacin—Oedema—Doxorubicin—pancreatic cancer	3.7e-05	0.000373	CcSEcCtD
Indomethacin—Shock—Doxorubicin—pancreatic cancer	3.64e-05	0.000367	CcSEcCtD
Indomethacin—Thrombocytopenia—Doxorubicin—pancreatic cancer	3.62e-05	0.000365	CcSEcCtD
Indomethacin—Insomnia—Epirubicin—pancreatic cancer	3.61e-05	0.000364	CcSEcCtD
Indomethacin—Tachycardia—Doxorubicin—pancreatic cancer	3.61e-05	0.000364	CcSEcCtD
Indomethacin—Paraesthesia—Epirubicin—pancreatic cancer	3.59e-05	0.000362	CcSEcCtD
Indomethacin—Hyperhidrosis—Doxorubicin—pancreatic cancer	3.57e-05	0.00036	CcSEcCtD
Indomethacin—Dyspnoea—Epirubicin—pancreatic cancer	3.56e-05	0.000359	CcSEcCtD
Indomethacin—Somnolence—Epirubicin—pancreatic cancer	3.55e-05	0.000358	CcSEcCtD
Indomethacin—Anorexia—Doxorubicin—pancreatic cancer	3.52e-05	0.000355	CcSEcCtD
Indomethacin—Nausea—Docetaxel—pancreatic cancer	3.52e-05	0.000355	CcSEcCtD
Indomethacin—Dyspepsia—Epirubicin—pancreatic cancer	3.52e-05	0.000355	CcSEcCtD
Indomethacin—Decreased appetite—Epirubicin—pancreatic cancer	3.47e-05	0.00035	CcSEcCtD
Indomethacin—Hypotension—Doxorubicin—pancreatic cancer	3.45e-05	0.000348	CcSEcCtD
Indomethacin—Fatigue—Epirubicin—pancreatic cancer	3.44e-05	0.000347	CcSEcCtD
Indomethacin—Pain—Epirubicin—pancreatic cancer	3.42e-05	0.000345	CcSEcCtD
Indomethacin—Constipation—Epirubicin—pancreatic cancer	3.42e-05	0.000345	CcSEcCtD
Indomethacin—Insomnia—Doxorubicin—pancreatic cancer	3.34e-05	0.000337	CcSEcCtD
Indomethacin—Paraesthesia—Doxorubicin—pancreatic cancer	3.32e-05	0.000335	CcSEcCtD
Indomethacin—Dyspnoea—Doxorubicin—pancreatic cancer	3.3e-05	0.000332	CcSEcCtD
Indomethacin—Feeling abnormal—Epirubicin—pancreatic cancer	3.29e-05	0.000332	CcSEcCtD
Indomethacin—Somnolence—Doxorubicin—pancreatic cancer	3.29e-05	0.000331	CcSEcCtD
Indomethacin—Gastrointestinal pain—Epirubicin—pancreatic cancer	3.27e-05	0.000329	CcSEcCtD
Indomethacin—Dyspepsia—Doxorubicin—pancreatic cancer	3.25e-05	0.000328	CcSEcCtD
Indomethacin—Decreased appetite—Doxorubicin—pancreatic cancer	3.21e-05	0.000324	CcSEcCtD
Indomethacin—Fatigue—Doxorubicin—pancreatic cancer	3.19e-05	0.000321	CcSEcCtD
Indomethacin—Urticaria—Epirubicin—pancreatic cancer	3.17e-05	0.00032	CcSEcCtD
Indomethacin—Pain—Doxorubicin—pancreatic cancer	3.16e-05	0.000319	CcSEcCtD
Indomethacin—Constipation—Doxorubicin—pancreatic cancer	3.16e-05	0.000319	CcSEcCtD
Indomethacin—Abdominal pain—Epirubicin—pancreatic cancer	3.16e-05	0.000318	CcSEcCtD
Indomethacin—Body temperature increased—Epirubicin—pancreatic cancer	3.16e-05	0.000318	CcSEcCtD
Indomethacin—Feeling abnormal—Doxorubicin—pancreatic cancer	3.05e-05	0.000307	CcSEcCtD
Indomethacin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	3.02e-05	0.000305	CcSEcCtD
Indomethacin—Hypersensitivity—Epirubicin—pancreatic cancer	2.94e-05	0.000297	CcSEcCtD
Indomethacin—Urticaria—Doxorubicin—pancreatic cancer	2.94e-05	0.000296	CcSEcCtD
Indomethacin—Body temperature increased—Doxorubicin—pancreatic cancer	2.92e-05	0.000295	CcSEcCtD
Indomethacin—Abdominal pain—Doxorubicin—pancreatic cancer	2.92e-05	0.000295	CcSEcCtD
Indomethacin—Asthenia—Epirubicin—pancreatic cancer	2.87e-05	0.000289	CcSEcCtD
Indomethacin—Pruritus—Epirubicin—pancreatic cancer	2.83e-05	0.000285	CcSEcCtD
Indomethacin—Diarrhoea—Epirubicin—pancreatic cancer	2.73e-05	0.000276	CcSEcCtD
Indomethacin—Hypersensitivity—Doxorubicin—pancreatic cancer	2.72e-05	0.000275	CcSEcCtD
Indomethacin—Asthenia—Doxorubicin—pancreatic cancer	2.65e-05	0.000267	CcSEcCtD
Indomethacin—Dizziness—Epirubicin—pancreatic cancer	2.64e-05	0.000266	CcSEcCtD
Indomethacin—Pruritus—Doxorubicin—pancreatic cancer	2.62e-05	0.000264	CcSEcCtD
Indomethacin—Vomiting—Epirubicin—pancreatic cancer	2.54e-05	0.000256	CcSEcCtD
Indomethacin—Diarrhoea—Doxorubicin—pancreatic cancer	2.53e-05	0.000255	CcSEcCtD
Indomethacin—Rash—Epirubicin—pancreatic cancer	2.52e-05	0.000254	CcSEcCtD
Indomethacin—Dermatitis—Epirubicin—pancreatic cancer	2.52e-05	0.000254	CcSEcCtD
Indomethacin—Headache—Epirubicin—pancreatic cancer	2.5e-05	0.000252	CcSEcCtD
Indomethacin—Dizziness—Doxorubicin—pancreatic cancer	2.44e-05	0.000247	CcSEcCtD
Indomethacin—Nausea—Epirubicin—pancreatic cancer	2.37e-05	0.000239	CcSEcCtD
Indomethacin—Vomiting—Doxorubicin—pancreatic cancer	2.35e-05	0.000237	CcSEcCtD
Indomethacin—Rash—Doxorubicin—pancreatic cancer	2.33e-05	0.000235	CcSEcCtD
Indomethacin—Dermatitis—Doxorubicin—pancreatic cancer	2.33e-05	0.000235	CcSEcCtD
Indomethacin—Headache—Doxorubicin—pancreatic cancer	2.32e-05	0.000234	CcSEcCtD
Indomethacin—Nausea—Doxorubicin—pancreatic cancer	2.2e-05	0.000221	CcSEcCtD
Indomethacin—AKR1C3—Disease—PIK3CA—pancreatic cancer	4.04e-06	6.08e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MMP9—pancreatic cancer	4.04e-06	6.07e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GLP1R—pancreatic cancer	4.03e-06	6.06e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—SLC2A2—pancreatic cancer	4.03e-06	6.06e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—PTEN—pancreatic cancer	4.02e-06	6.03e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PPARG—pancreatic cancer	4e-06	6.02e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4e-06	6.01e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—STK11—pancreatic cancer	3.97e-06	5.96e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—DPYD—pancreatic cancer	3.97e-06	5.96e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PIK3CD—pancreatic cancer	3.96e-06	5.95e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.94e-06	5.93e-05	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—PIK3CA—pancreatic cancer	3.94e-06	5.92e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—APOE—pancreatic cancer	3.93e-06	5.91e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PIK3CD—pancreatic cancer	3.92e-06	5.89e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.92e-06	5.89e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PIK3CG—pancreatic cancer	3.87e-06	5.82e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PIK3CG—pancreatic cancer	3.87e-06	5.82e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—PIK3CB—pancreatic cancer	3.83e-06	5.76e-05	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—AKT1—pancreatic cancer	3.78e-06	5.69e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—PIK3CA—pancreatic cancer	3.78e-06	5.68e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	3.77e-06	5.66e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—HRAS—pancreatic cancer	3.74e-06	5.62e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PPARG—pancreatic cancer	3.74e-06	5.62e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PPARG—pancreatic cancer	3.74e-06	5.62e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PIK3CG—pancreatic cancer	3.73e-06	5.61e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.73e-06	5.6e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.73e-06	5.6e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—SRC—pancreatic cancer	3.72e-06	5.6e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.72e-06	5.59e-05	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	3.7e-06	5.56e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PIK3CB—pancreatic cancer	3.67e-06	5.51e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PIK3CB—pancreatic cancer	3.65e-06	5.49e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PIK3CB—pancreatic cancer	3.65e-06	5.49e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PIK3CD—pancreatic cancer	3.65e-06	5.48e-05	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	3.64e-06	5.48e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—VEGFA—pancreatic cancer	3.63e-06	5.45e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PTGS2—pancreatic cancer	3.62e-06	5.44e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PTGS2—pancreatic cancer	3.62e-06	5.44e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PPARG—pancreatic cancer	3.6e-06	5.42e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.6e-06	5.4e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.59e-06	5.4e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—STAT3—pancreatic cancer	3.59e-06	5.4e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—NRAS—pancreatic cancer	3.58e-06	5.38e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CD44—pancreatic cancer	3.56e-06	5.35e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—TERT—pancreatic cancer	3.55e-06	5.34e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PIK3CG—pancreatic cancer	3.55e-06	5.33e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—HRAS—pancreatic cancer	3.5e-06	5.26e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—APOE—pancreatic cancer	3.5e-06	5.26e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.49e-06	5.24e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.46e-06	5.19e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PIK3CB—pancreatic cancer	3.45e-06	5.19e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PPARG—pancreatic cancer	3.42e-06	5.15e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PTGS2—pancreatic cancer	3.42e-06	5.14e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PIK3CB—pancreatic cancer	3.42e-06	5.13e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GCG—pancreatic cancer	3.42e-06	5.13e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—TYMS—pancreatic cancer	3.41e-06	5.13e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PIK3CD—pancreatic cancer	3.4e-06	5.12e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PIK3CD—pancreatic cancer	3.4e-06	5.12e-05	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—AKT1—pancreatic cancer	3.4e-06	5.11e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—HIF1A—pancreatic cancer	3.4e-06	5.1e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—TSC2—pancreatic cancer	3.39e-06	5.09e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—PIK3CA—pancreatic cancer	3.39e-06	5.09e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PTGS2—pancreatic cancer	3.39e-06	5.09e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CASP3—pancreatic cancer	3.37e-06	5.07e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MYC—pancreatic cancer	3.34e-06	5.01e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TGFB1—pancreatic cancer	3.33e-06	5e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—APOE—pancreatic cancer	3.32e-06	4.98e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.31e-06	4.98e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—AKT1—pancreatic cancer	3.3e-06	4.97e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PIK3CD—pancreatic cancer	3.28e-06	4.93e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CCND1—pancreatic cancer	3.28e-06	4.93e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.28e-06	4.92e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—EGFR—pancreatic cancer	3.26e-06	4.9e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CTNNB1—pancreatic cancer	3.25e-06	4.88e-05	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—AKT1—pancreatic cancer	3.22e-06	4.84e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—STK11—pancreatic cancer	3.21e-06	4.83e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CD44—pancreatic cancer	3.2e-06	4.81e-05	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—MYC—pancreatic cancer	3.19e-06	4.79e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MMP9—pancreatic cancer	3.19e-06	4.79e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PIK3CB—pancreatic cancer	3.18e-06	4.78e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PTEN—pancreatic cancer	3.17e-06	4.76e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CG—pancreatic cancer	3.16e-06	4.74e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PTEN—pancreatic cancer	3.16e-06	4.74e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PTEN—pancreatic cancer	3.16e-06	4.74e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PTGS2—pancreatic cancer	3.15e-06	4.73e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.13e-06	4.71e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CD44—pancreatic cancer	3.12e-06	4.69e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PIK3CD—pancreatic cancer	3.12e-06	4.69e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.1e-06	4.66e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—AKT1—pancreatic cancer	3.09e-06	4.64e-05	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—AKT1—pancreatic cancer	3.09e-06	4.64e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—KRAS—pancreatic cancer	3.08e-06	4.63e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—SRC—pancreatic cancer	3.07e-06	4.61e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GCG—pancreatic cancer	3.07e-06	4.61e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NOTCH1—pancreatic cancer	3.06e-06	4.6e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PPARG—pancreatic cancer	3.05e-06	4.58e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CTNNB1—pancreatic cancer	3.03e-06	4.55e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.01e-06	4.53e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GCG—pancreatic cancer	2.99e-06	4.5e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—VEGFA—pancreatic cancer	2.99e-06	4.49e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PTEN—pancreatic cancer	2.98e-06	4.48e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PIK3CB—pancreatic cancer	2.97e-06	4.46e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PIK3CB—pancreatic cancer	2.97e-06	4.46e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—EGF—pancreatic cancer	2.96e-06	4.44e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—NRAS—pancreatic cancer	2.95e-06	4.44e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PTEN—pancreatic cancer	2.95e-06	4.44e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTGS2—pancreatic cancer	2.94e-06	4.42e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTGS2—pancreatic cancer	2.94e-06	4.42e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—SRC—pancreatic cancer	2.94e-06	4.41e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PIK3CA—pancreatic cancer	2.94e-06	4.41e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CD44—pancreatic cancer	2.92e-06	4.38e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—STK11—pancreatic cancer	2.88e-06	4.33e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PIK3CB—pancreatic cancer	2.86e-06	4.3e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—VEGFA—pancreatic cancer	2.86e-06	4.3e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.86e-06	4.29e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTGS2—pancreatic cancer	2.83e-06	4.26e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—STAT3—pancreatic cancer	2.83e-06	4.26e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—PIK3CA—pancreatic cancer	2.83e-06	4.26e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.83e-06	4.25e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—NRAS—pancreatic cancer	2.83e-06	4.25e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—STK11—pancreatic cancer	2.81e-06	4.23e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GCG—pancreatic cancer	2.8e-06	4.2e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—APOE—pancreatic cancer	2.78e-06	4.17e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CD—pancreatic cancer	2.78e-06	4.17e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—AKT1—pancreatic cancer	2.77e-06	4.16e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—TYMS—pancreatic cancer	2.76e-06	4.15e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PTEN—pancreatic cancer	2.75e-06	4.13e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TGFB1—pancreatic cancer	2.74e-06	4.12e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TP53—pancreatic cancer	2.74e-06	4.12e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—SRC—pancreatic cancer	2.74e-06	4.11e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PIK3CB—pancreatic cancer	2.72e-06	4.09e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.71e-06	4.07e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTGS2—pancreatic cancer	2.69e-06	4.05e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—STAT3—pancreatic cancer	2.64e-06	3.97e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—NRAS—pancreatic cancer	2.63e-06	3.96e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MYC—pancreatic cancer	2.63e-06	3.96e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PIK3CD—pancreatic cancer	2.63e-06	3.95e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—STK11—pancreatic cancer	2.63e-06	3.95e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.63e-06	3.95e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TGFB1—pancreatic cancer	2.63e-06	3.95e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—HRAS—pancreatic cancer	2.62e-06	3.94e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—EGFR—pancreatic cancer	2.57e-06	3.87e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTEN—pancreatic cancer	2.56e-06	3.85e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTEN—pancreatic cancer	2.56e-06	3.85e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—KRAS—pancreatic cancer	2.54e-06	3.82e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CG—pancreatic cancer	2.51e-06	3.77e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—TYMS—pancreatic cancer	2.48e-06	3.73e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTEN—pancreatic cancer	2.47e-06	3.72e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.47e-06	3.71e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MYC—pancreatic cancer	2.45e-06	3.69e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—TGFB1—pancreatic cancer	2.45e-06	3.68e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—KRAS—pancreatic cancer	2.43e-06	3.65e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—TYMS—pancreatic cancer	2.42e-06	3.64e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CB—pancreatic cancer	2.42e-06	3.63e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PPARG—pancreatic cancer	2.42e-06	3.63e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—EGFR—pancreatic cancer	2.4e-06	3.61e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—AKT1—pancreatic cancer	2.4e-06	3.61e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTGS2—pancreatic cancer	2.4e-06	3.6e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTEN—pancreatic cancer	2.35e-06	3.53e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—PIK3CA—pancreatic cancer	2.34e-06	3.51e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—AKT1—pancreatic cancer	2.31e-06	3.48e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PIK3CB—pancreatic cancer	2.29e-06	3.45e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—KRAS—pancreatic cancer	2.27e-06	3.41e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—TYMS—pancreatic cancer	2.26e-06	3.4e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TP53—pancreatic cancer	2.26e-06	3.4e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—APOE—pancreatic cancer	2.25e-06	3.38e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PIK3CA—pancreatic cancer	2.23e-06	3.36e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PIK3CA—pancreatic cancer	2.23e-06	3.35e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PIK3CA—pancreatic cancer	2.23e-06	3.35e-05	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—AKT1—pancreatic cancer	2.21e-06	3.32e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CD—pancreatic cancer	2.2e-06	3.31e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TP53—pancreatic cancer	2.16e-06	3.25e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—HRAS—pancreatic cancer	2.16e-06	3.25e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.13e-06	3.2e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PIK3CA—pancreatic cancer	2.1e-06	3.16e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTEN—pancreatic cancer	2.09e-06	3.14e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PIK3CA—pancreatic cancer	2.08e-06	3.13e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—HRAS—pancreatic cancer	2.07e-06	3.11e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CTNNB1—pancreatic cancer	2.03e-06	3.05e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CG—pancreatic cancer	2.03e-06	3.05e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—APOE—pancreatic cancer	2.02e-06	3.03e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PTEN—pancreatic cancer	1.98e-06	2.98e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—APOE—pancreatic cancer	1.97e-06	2.96e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PPARG—pancreatic cancer	1.96e-06	2.94e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PIK3CA—pancreatic cancer	1.94e-06	2.91e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—HRAS—pancreatic cancer	1.93e-06	2.9e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CB—pancreatic cancer	1.92e-06	2.89e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.91e-06	2.87e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—AKT1—pancreatic cancer	1.91e-06	2.87e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—APOE—pancreatic cancer	1.84e-06	2.76e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—SRC—pancreatic cancer	1.84e-06	2.76e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—AKT1—pancreatic cancer	1.83e-06	2.74e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	1.82e-06	2.74e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—AKT1—pancreatic cancer	1.82e-06	2.73e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—AKT1—pancreatic cancer	1.82e-06	2.73e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PIK3CA—pancreatic cancer	1.81e-06	2.72e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PIK3CA—pancreatic cancer	1.81e-06	2.72e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CD—pancreatic cancer	1.78e-06	2.68e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CG—pancreatic cancer	1.78e-06	2.67e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—STAT3—pancreatic cancer	1.77e-06	2.66e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NRAS—pancreatic cancer	1.77e-06	2.66e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PPARG—pancreatic cancer	1.76e-06	2.64e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PIK3CA—pancreatic cancer	1.74e-06	2.62e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.74e-06	2.62e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—AKT1—pancreatic cancer	1.72e-06	2.58e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PPARG—pancreatic cancer	1.71e-06	2.58e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—AKT1—pancreatic cancer	1.7e-06	2.56e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	1.66e-06	2.49e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PTEN—pancreatic cancer	1.66e-06	2.49e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PIK3CA—pancreatic cancer	1.66e-06	2.49e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MYC—pancreatic cancer	1.65e-06	2.47e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—TGFB1—pancreatic cancer	1.64e-06	2.47e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—EGFR—pancreatic cancer	1.61e-06	2.42e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PPARG—pancreatic cancer	1.6e-06	2.41e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	1.6e-06	2.4e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—AKT1—pancreatic cancer	1.58e-06	2.38e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CD—pancreatic cancer	1.56e-06	2.35e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CB—pancreatic cancer	1.55e-06	2.33e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTGS2—pancreatic cancer	1.54e-06	2.31e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—KRAS—pancreatic cancer	1.52e-06	2.29e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—AKT1—pancreatic cancer	1.48e-06	2.22e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—AKT1—pancreatic cancer	1.48e-06	2.22e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CA—pancreatic cancer	1.47e-06	2.22e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	1.46e-06	2.19e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—AKT1—pancreatic cancer	1.42e-06	2.14e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PIK3CA—pancreatic cancer	1.4e-06	2.1e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	1.39e-06	2.1e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTGS2—pancreatic cancer	1.38e-06	2.08e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CB—pancreatic cancer	1.36e-06	2.05e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—AKT1—pancreatic cancer	1.35e-06	2.03e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTGS2—pancreatic cancer	1.35e-06	2.03e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTEN—pancreatic cancer	1.34e-06	2.02e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—HRAS—pancreatic cancer	1.29e-06	1.94e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	1.27e-06	1.91e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTGS2—pancreatic cancer	1.26e-06	1.89e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTEN—pancreatic cancer	1.21e-06	1.81e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—AKT1—pancreatic cancer	1.2e-06	1.81e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTEN—pancreatic cancer	1.18e-06	1.77e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CA—pancreatic cancer	1.17e-06	1.76e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—AKT1—pancreatic cancer	1.14e-06	1.72e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTEN—pancreatic cancer	1.1e-06	1.65e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—AKT1—pancreatic cancer	9.56e-07	1.44e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CA—pancreatic cancer	9.47e-07	1.42e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	8.5e-07	1.28e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CA—pancreatic cancer	8.3e-07	1.25e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	7.75e-07	1.16e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—AKT1—pancreatic cancer	7.74e-07	1.16e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—AKT1—pancreatic cancer	6.94e-07	1.04e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—AKT1—pancreatic cancer	6.78e-07	1.02e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—AKT1—pancreatic cancer	6.33e-07	9.52e-06	CbGpPWpGaD
